Mortality in Peripheral Vascular Disease Drops Due to Revascularization

This cohort study shows that, from 2006 to 2015, the overall survival rate increased and the risk of major amputation decreased following lower limb revascularization. These population observations indicate that outcomes after lower limb revascularization have improved during the assessed period, and so have the centralization and specialization of interventional services.

The availability and diversity of sites where lower limb revascularization procedures can be carried out have increased all over the world in the last decade (although this work provides information regarding England, specifically). This study sought to determine whether the mastery of skills by interventional professionals and technology development (with many more improvements for peripheral disease than for coronary disease) have had an impact on patient prognosis.

 

Researchers used a database with information on 103,934 patients who underwent endovascular (angioplasty) or surgical (endarterectomy, profundaplasty, or bypass) treatment for infrainguinal peripheral vascular disease between 2006 and 2015.


Read also: The Dangerous Combination of Complex Angioplasty and High Bleeding Risk Seems to Have a Solution.


The estimated 1-year risk of major amputation decreased from 5.7% (in 2006-2007) to 3.9% (in 2014-2015) after endovascular revascularization, and from 11.2% (in 2006-2007) to 6.6% (in 2014-2015) after surgical revascularization. The risk of death after both types of revascularization also decreased. This trend was observed for all indications. The largest reduction was found in patients with critical ischemia, ulceration, or gangrene.

 

Conclusion

Overall survival improved and the rate of major amputation decreased between 2006 and 2015, with a higher number of revascularizations. Results improve over time due to the emergence of specialized sites where procedures are centralized. However, this still has not happened in many places, and many patients have amputations without even undergoing a diagnostic angiography.

 

Original title: Improving 1-Year Outcomes of Infrainguinal Limb Revascularization: A Population-Based Cohort Study of 104 000 Patients in England.

Reference: Katriina Heikkila et al. Circulation. 2018 May 1;137(18):1921-1933.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...